YOLOAdvisorShares Pure Cannabis ETF
Seeks long-term capital appreciation.
By AdvisorShares · Launched 2019
Annual Cost
0.51%
#2,800 of 5,861 · average
Fund Size
$34M
#4,026 of 5,861 · small
Return (1Y)Goal
+18.1%
Track Record
7 years
#1,863 of 5,861 · established
Performance
Total-return NAV · USDGrowth of $10,000
$10,812+8.1%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 99.4% of fundconcentrated
AdvisorShares Trust
47.2%
Village Farms Inte
18.5%
High Tide Inc
9.7%
Charlottes Web Holdings Inc
5.2%
Cronos Group Inc
4.3%
Organigram Global Inc.
4.0%
SNDL Inc
3.7%
DREY INST PREF GOV MM-MDSVXX
3.2%
Aurora Cannabis Inc
1.8%
Rubicon Organics Inc
1.7%
Asset allocation
Stocks
75.4%
Cash
14.4%
Bonds
8.5%
Other
1.6%
By sector
Healthcare
83.9%
Consumer Defensive
16.1%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
75.1%High
Year-on-year price swings
Max drawdown
-94.7%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.23Below average
Sortino (3Y)
0.38Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Actively manages an ETF investing primarily in mid- and small-cap companies deriving at least 50% of revenue from marijuana and hemp. Concentrates at least 25% in the pharmaceuticals, biotechnology & life sciences sector within health care, focusing on growth opportunities.
- Inception date
- April 17, 2019
- Fund family
- AdvisorShares
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at YOLO. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04